Samsara secures more funding for cellular rejuvenation drug research

06-Mar-2019
KEY POINTS FROM ARTICLE:

Samsara Therapeutics is developing drugs to rejuvenate cells.
Has completed a seed financing round in collaboration with Apollo Ventures,
Currently focusing on autophagy - the cell's natural garbage disposal system .
Using a sophisticated drug screening platform to discover potential geroprotectors.
Samsara recently identified the flavonoid 4,4′-dimethoxychalcone (DMC).

Drugs will need to work better than the free alternative - calorie restriction
Read full article on Life Extension Advocacy Foundation (LEAF) website
More Longevity Industry Investments information, news and resources